STRUCTURAL BASIS OF NEUROTOXICITY BY TUBULIN-TARGETING ANTITUMOR DRUGS: TOWARDS BETTER MICROTUBULE MODULATING AGENTS AGAINST CANCER AND NEURODEGENERATIVE DISEASES
STRUCTURAL BASIS OF NEUROTOXICITY BY TUBULIN-TARGETING ANTITUMOR DRUGS: TOWARDS BETTER MICROTUBULE MODULATING AGENTS AGAINST CANCER AND NEURODEGENERATIVE DISEASES